Health Care & Life Sciences » Pharmaceuticals | Sun Pharma Advanced Research Co.

Sun Pharma Advanced Research Co. | Mutual Funds

Mutual Funds that own Sun Pharma Advanced Research Co.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Seafarer Overseas Growth & Income Fund
8,537,041
3.4%
-87,959
1.95%
06/30/2018
UTI - Mid Cap Fund
1,493,961
0.6%
54,823
1.49%
08/31/2018
Government Pension Fund - Global (The)
1,306,082
0.52%
1,306,082
0%
12/31/2017
Vanguard Total International Stock Index Fund
1,207,052
0.48%
80,157
0%
07/31/2018
iShares Core MSCI Emerging Markets ETF
1,145,643
0.46%
0
0.01%
09/05/2018
Vanguard Emerging Markets Stock Index Fund
1,078,982
0.43%
-12,390
0.01%
07/31/2018
Axis Focused 25 Fund
1,029,979
0.41%
139,727
0.75%
07/31/2018
Axis Long Term Equity Fund
979,867
0.39%
0
0.21%
07/31/2018
JPMorgan Funds - India Fund
935,997
0.37%
0
0.6%
03/31/2018
DSP BlackRock Micro Cap Fund
460,341
0.18%
0
0.32%
02/28/2018

About Sun Pharma Advanced Research

View Profile
Address
17 B Mahal Industrial Estate
Mumbai Maharashtra 400093
India
Employees -
Website http://www.sunpharma.in
Updated 09/14/2018
Sun Pharma Advanced Research Co. Ltd. is a bio-pharmaceutical company, which engages in the research and development of pharmaceuticals. Its projects include new chemical entity research and novel drug delivery systems. The company was founded on March 1, 2006 and is headquartered in Mumbai, India.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.